


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
SIGI
Selective Insurance
$78.29
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$75.61 (+3.54%)
$78.23 (+0.08%)
$86.33 (-9.31%)
$98.81 (-20.77%)
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

SIGI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SIGI Street Sentiment is unimpressive but have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is SIGI current stock price?
What are SIGI stock strengths?
What is SIGI Risk Level?
What is SIGI market cap and volume?
What is SIGI current Stock IQ?
Should I buy SIGI stock right now?
Is SIGI a Strong Buy right now?
What does a 'Strong Buy' rating mean for SIGI?
What does a 'Strong Sell' rating mean for SIGI?
What factors influence SIGI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
SIGI
Selective Insurance
Current Price
$78.29
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Chart
$75.61 (+3.54%)
$78.23 (+0.08%)
$86.33 (-9.31%)
$98.81 (-20.77%)
SIGI Analysts Opinion
SIGI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SIGI Street Sentiment is unimpressive but have positive views on the near-term outlook
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels.
SIGI Latest Analysis
As Penny Production Ends Copper Bonds Show Selective Strength Says Gimme Credit. NEW YORK Nov. 24 2025 /PRNewswire/ -- As the United States retires the penny Gimme Credit offers a pocket full of insights on the copper sector. According to its expert team of corporate bond analysts copper is entering a pivotal phase marked by rising long-term demand tightening supply...
Today
FIIs trim stakes in GRSE BDL and 10 more defence stocks in Sept. Why is the firepower lacking? . Foreign institutional investors reduced stakes in several Indian defence stocks during the September quarter citing valuation concerns and slower-than-expected order inflows. Despite this pullback mutual funds showed increased buying interest indicating a selective shift in investor preference within the sector.
Tue Nov 18, 2025
How To Pick The Right Small-Cap Stocks For Your Portfolio: Fortress Vs. Zombie Small-Caps. Russell 2000 companies collectively carry over $800 billion in debt with approximately $368 billion maturing in 2026 and another $341 billion in 2027. Here’.s the problem tough. 43% of small-caps are unprofitable double the 2008 crisis level yet they’.re all being sold off together when credit concerns rise. The market can’.t distinguish between fortress companies with zero debt and double-d
Mon Nov 17, 2025
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight. KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape |. DelveInsightThe KRAS inhibitors market is expected to experience substantial growth driven by rising cancer incidence improved treatment access and a robust pipeline including Olomorasib (E
Wed Nov 12, 2025
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia. CAMBRIDGE United Kingdom and LEXINGTON Mass. Nov. 10 2025 (GLOBE NEWSWIRE) -- Transition Bio a drug discovery company focused on unlocking traditionally undruggable targets by leveraging biomolecular condensates and Voyager Therapeutics (Nasdaq: VYGR) a biotechnology company dedicated to leveraging genetics to treat neurological diseases have entered into a drug disco
Mon Nov 10, 2025
Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity. Oral MC4R agonist PL7737 demonstrated robust weight loss safety and high oral bioavailability in preclinical modelsClinical data supports co-administration of an MC4R agonist with tirzepatide as a safe potentially synergistic approach to weight managementPL7737 IND-enabling toxicology underway with an IND submission and clinical trial initiation planned for the first half of 2026. clinica
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SIGI Stock trends
SIGI Stock performance
SIGI Stock analysis
SIGI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.